Crossmark

Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis

Crossref DOI link: https://doi.org/10.1186/s13041-021-00787-6

Published Online: 2021-05-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Magota, Hirotoshi

Sasaki, Masanori https://orcid.org/0000-0001-7961-9698
Kataoka-Sasaki, Yuko

Oka, Shinichi

Ukai, Ryo

Kiyose, Ryo

Onodera, Rie

Kocsis, Jeffery D.

Honmou, Osamu
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (17K10844)

Japan Society for the Promotion of Science (18K08974)

Japan Agency for Medical Research and Development (JP17lm0203024)

Northern Advancement Center for Science and Technology (H30 SL-5)
License Information

Text and Data Mining valid from 2021-05-07

Version of Record valid from 2021-05-07
More Information

Article History

Received: 22 March 2021

Accepted: 30 April 2021

First Online: 7 May 2021

Declarations

:

: The use of animals in this study was approved by the Animal Care and Use Committee and the Committee for Security of Recombinant DNA Experiments at Sapporo Medical University. All procedures were performed in accordance with institutional guidelines.Consent for publicationNot applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below